Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected?

Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected? BACKGROUNDMonoclonal antibodies (mAb) are antibodies that are made by identical immune cells derived from a unique parent B lymphocyte cell. During the past few decades, mAbs have become an integral and widely used technology for both laboratory diagnostics and clinical treatment. As it the case for many other prescription drugs, it is necessary to perform clinical laboratory tests before and after the treatment with therapeutic mAb to screen for potentially sensitive patients, check the patients’ background health status and to evaluate the response to treatment. It has also been reported that some mAbs may interfere with clinical laboratory tests, especially diagnostic kits that use mAb to detect a specific analyte. However, to the best of our knowledge, there have not been any systematic review about the clinical laboratory tests needed for and affected by therapeutic mAb based on the drug labels.Drug labels provide an excellent source of data for pharmacoepidemiological studies because they contain detailed information about the individual drugs. Therefore, we reviewed and analyzed all the labels of FDA‐approved therapeutic mAbs deposited in DailyMed, the official website for FDA‐approved drug labels (https://dailymed.nlm.nih.gov/dailymed/index.cfm), to provide a detailed profile of the clinical laboratory tests which should be performed before, during http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Laboratory Analysis Wiley

Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected?

Loading next page...
 
/lp/wiley/therapeutic-monoclonal-antibodies-and-clinical-laboratory-tests-when-KAYWlxOHyC
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Wiley Periodicals, Inc.
ISSN
0887-8013
eISSN
1098-2825
D.O.I.
10.1002/jcla.22307
Publisher site
See Article on Publisher Site

Abstract

BACKGROUNDMonoclonal antibodies (mAb) are antibodies that are made by identical immune cells derived from a unique parent B lymphocyte cell. During the past few decades, mAbs have become an integral and widely used technology for both laboratory diagnostics and clinical treatment. As it the case for many other prescription drugs, it is necessary to perform clinical laboratory tests before and after the treatment with therapeutic mAb to screen for potentially sensitive patients, check the patients’ background health status and to evaluate the response to treatment. It has also been reported that some mAbs may interfere with clinical laboratory tests, especially diagnostic kits that use mAb to detect a specific analyte. However, to the best of our knowledge, there have not been any systematic review about the clinical laboratory tests needed for and affected by therapeutic mAb based on the drug labels.Drug labels provide an excellent source of data for pharmacoepidemiological studies because they contain detailed information about the individual drugs. Therefore, we reviewed and analyzed all the labels of FDA‐approved therapeutic mAbs deposited in DailyMed, the official website for FDA‐approved drug labels (https://dailymed.nlm.nih.gov/dailymed/index.cfm), to provide a detailed profile of the clinical laboratory tests which should be performed before, during

Journal

Journal of Clinical Laboratory AnalysisWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off